Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Schlattner

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
International Journal of Molecular Sciences|December 10, 2021
The Complex Functions of the NME Family-A Matter of Location and Molecular ActivityUwe Schlattner
Metabolic Engineering|July 17, 2004
Inverse metabolic engineering with phosphagen kinase systems improves the cellular energy stateUwe Sauer, Uwe Schlattner
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 6, 2010
Creatine kinases: a cornerstone for structural research in the phosphagen kinase familyTheo Wallimann, Uwe Schlattner
Molecular Metabolism|March 21, 2024
Response to letter-to-the-editor: "Acetyl-CoA synthetase (ACSS2) does not generate butyryl- and crotonyl-CoA"Uwe Schlattner, Saadi Khochbin, Carlo Petosa
The Journal of Biological Chemistry|October 29, 2002
Differential effects of peroxynitrite on human mitochondrial creatine kinase isoenzymes. Inactivation, octamer destabilization, and identification of involved residuesSilke Wendt, Uwe Schlattner, Theo Wallimann
Chemistry & Biology|May 27, 2014
Bypassing AMPK phosphorylationBenoit Viollet, Marc Foretz, Uwe Schlattner
The Journal of Physiology|June 4, 2005
Calcium and energy transferValdur A Saks, Theo Wallimann, Uwe Schlattner
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 17, 2018
The NDPK/NME superfamily: state of the artMathieu Boissan, Uwe Schlattner, Marie-Lise Lacombe
Molecular Pharmacology|February 21, 2002
Multiple interference of anthracyclines with mitochondrial creatine kinases: preferential damage of the cardiac isoenzyme and its implications for drug cardiotoxicityMalgorzata Tokarska-Schlattner, Theo Wallimann, Uwe Schlattner
Comptes Rendus Biologies|September 2, 2006
Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicinMalgorzata Tokarska-Schlattner, Theo Wallimann, Uwe Schlattner
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
International Journal of Molecular Sciences|December 10, 2021
The Complex Functions of the NME Family-A Matter of Location and Molecular ActivityUwe Schlattner
Metabolic Engineering|July 17, 2004
Inverse metabolic engineering with phosphagen kinase systems improves the cellular energy stateUwe Sauer, Uwe Schlattner
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 6, 2010
Creatine kinases: a cornerstone for structural research in the phosphagen kinase familyTheo Wallimann, Uwe Schlattner
Molecular Metabolism|March 21, 2024
Response to letter-to-the-editor: "Acetyl-CoA synthetase (ACSS2) does not generate butyryl- and crotonyl-CoA"Uwe Schlattner, Saadi Khochbin, Carlo Petosa
The Journal of Biological Chemistry|October 29, 2002
Differential effects of peroxynitrite on human mitochondrial creatine kinase isoenzymes. Inactivation, octamer destabilization, and identification of involved residuesSilke Wendt, Uwe Schlattner, Theo Wallimann
Chemistry & Biology|May 27, 2014
Bypassing AMPK phosphorylationBenoit Viollet, Marc Foretz, Uwe Schlattner
The Journal of Physiology|June 4, 2005
Calcium and energy transferValdur A Saks, Theo Wallimann, Uwe Schlattner
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 17, 2018
The NDPK/NME superfamily: state of the artMathieu Boissan, Uwe Schlattner, Marie-Lise Lacombe
Molecular Pharmacology|February 21, 2002
Multiple interference of anthracyclines with mitochondrial creatine kinases: preferential damage of the cardiac isoenzyme and its implications for drug cardiotoxicityMalgorzata Tokarska-Schlattner, Theo Wallimann, Uwe Schlattner
Comptes Rendus Biologies|September 2, 2006
Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicinMalgorzata Tokarska-Schlattner, Theo Wallimann, Uwe Schlattner
Pageof 14